Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Gross Margin (2016 - 2025)

Historic Gross Margin for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 57.11%.

  • Utah Medical Products' Gross Margin fell 8800.0% to 57.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 57.1%, marking a year-over-year decrease of 17000.0%. This contributed to the annual value of 59.03% for FY2024, which is 7800.0% down from last year.
  • Latest data reveals that Utah Medical Products reported Gross Margin of 57.11% as of Q3 2025, which was down 8800.0% from 56.21% recorded in Q2 2025.
  • Utah Medical Products' Gross Margin's 5-year high stood at 64.21% during Q3 2021, with a 5-year trough of 56.21% in Q2 2025.
  • For the 5-year period, Utah Medical Products' Gross Margin averaged around 60.21%, with its median value being 60.15% (2023).
  • In the last 5 years, Utah Medical Products' Gross Margin soared by 54300bps in 2021 and then crashed by -43400bps in 2023.
  • Quarter analysis of 5 years shows Utah Medical Products' Gross Margin stood at 62.82% in 2021, then fell by -2bps to 61.34% in 2022, then decreased by -6bps to 57.55% in 2023, then rose by 1bps to 58.13% in 2024, then decreased by -2bps to 57.11% in 2025.
  • Its last three reported values are 57.11% in Q3 2025, 56.21% for Q2 2025, and 57.03% during Q1 2025.